AngioDynamics
Focus: AngioDynamics is a medical device company headquartered in Hong Kong with a broad portfolio spanning oncology, vascular, and interventional devices. The company develops minimally invasive treatment systems across multiple therapeutic areas.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
2
Should You Work at AngioDynamics?
AI assessmentAngioDynamics is a niche device innovator with promising late-stage programs, but minimal hiring and opaque financials make it a high-risk career move for most professionals.
Why Work Here
- Diversified device portfolio spanning oncology (NanoKnife, radiofrequency ablation) and vascular diseases (Auryon, VenaCure EVLT) reduces single-product dependency risk.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Irreversible Electroporation (NanoKnife System)
Prostate CancerMechanical Aspiration System (AlphaVac)
Acute Pulmonary EmbolismHelp build intelligence for AngioDynamics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.